DK0437604T3 - Rekombinant poxvirus- og streptokok M-proteinvaccine - Google Patents

Rekombinant poxvirus- og streptokok M-proteinvaccine

Info

Publication number
DK0437604T3
DK0437604T3 DK90917006T DK90917006T DK0437604T3 DK 0437604 T3 DK0437604 T3 DK 0437604T3 DK 90917006 T DK90917006 T DK 90917006T DK 90917006 T DK90917006 T DK 90917006T DK 0437604 T3 DK0437604 T3 DK 0437604T3
Authority
DK
Denmark
Prior art keywords
streptococcal
protein vaccine
recombinant poxvirus
protein
viruses
Prior art date
Application number
DK90917006T
Other languages
Danish (da)
English (en)
Inventor
Vincent A Fischetti
Dennis E Hruby
Original Assignee
Univ Rockefeller
State Of Oregon Oregon State U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller, State Of Oregon Oregon State U filed Critical Univ Rockefeller
Application granted granted Critical
Publication of DK0437604T3 publication Critical patent/DK0437604T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus
DK90917006T 1989-06-21 1990-06-21 Rekombinant poxvirus- og streptokok M-proteinvaccine DK0437604T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36911889A 1989-06-21 1989-06-21
US54058690A 1990-06-19 1990-06-19
PCT/US1990/003531 WO1990015872A1 (en) 1989-06-21 1990-06-21 Recombinant poxvirus and streptococcal m protein vaccine

Publications (1)

Publication Number Publication Date
DK0437604T3 true DK0437604T3 (da) 2003-09-15

Family

ID=27004462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917006T DK0437604T3 (da) 1989-06-21 1990-06-21 Rekombinant poxvirus- og streptokok M-proteinvaccine

Country Status (10)

Country Link
US (1) US5985654A (ja)
EP (1) EP0437604B1 (ja)
JP (1) JP2577280B2 (ja)
AT (1) ATE240396T1 (ja)
AU (3) AU5948490A (ja)
CA (1) CA2035039C (ja)
DE (1) DE69034075T2 (ja)
DK (1) DK0437604T3 (ja)
ES (1) ES2199932T3 (ja)
WO (1) WO1990015872A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
SE9002213D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Albumin binding proteins
EP0672123A1 (en) * 1992-01-08 1995-09-20 The Rockefeller University Multifunctional surface protein of streptococci
CA2131995A1 (en) * 1992-03-13 1993-09-16 Vincent A. Fischetti Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
WO1993021220A1 (en) * 1992-04-08 1993-10-28 The Council Of The Queensland Institute Of Medical Research Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
US5882896A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US6716433B1 (en) * 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US20030082110A1 (en) * 1997-10-31 2003-05-01 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US7063837B2 (en) * 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
WO2003060143A2 (en) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Efficient protein expression system
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
BRPI0604997A (pt) 2006-11-30 2007-05-22 Fundacao Zerbini vacina contra o estreptococo beta hemolìtico do grupo a, e respectivo processo de obtenção
US9289485B2 (en) 2006-11-30 2016-03-22 Luiza Guilherme Guglielmi Therapeutic application of S. pyogenes C-terminal peptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784948A (en) * 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
GB8508845D0 (en) * 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
AU630093B2 (en) * 1988-03-25 1992-10-22 Rockefeller University, The Synthetic peptides from streptococcal m protein and vaccines prepared therefrom

Also Published As

Publication number Publication date
ES2199932T3 (es) 2004-03-01
EP0437604A1 (en) 1991-07-24
AU682344B2 (en) 1997-10-02
JP2577280B2 (ja) 1997-01-29
AU2855397A (en) 1997-10-02
EP0437604B1 (en) 2003-05-14
DE69034075D1 (de) 2003-06-18
AU5948490A (en) 1991-01-08
CA2035039A1 (en) 1990-12-22
JPH03504336A (ja) 1991-09-26
US5985654A (en) 1999-11-16
ATE240396T1 (de) 2003-05-15
WO1990015872A1 (en) 1990-12-27
DE69034075T2 (de) 2004-04-01
EP0437604A4 (en) 1991-11-13
CA2035039C (en) 2000-02-01
AU6307494A (en) 1994-07-14

Similar Documents

Publication Publication Date Title
DK0437604T3 (da) Rekombinant poxvirus- og streptokok M-proteinvaccine
GB2269820A (en) Flavivirus recombinant poxvirus vaccine
IT9020063A0 (it) Vaccino di poxvirus ricombinante di herpesvirus
DK0592546T3 (da) Immundeficiens-virus rekombinant poxvirus-vaccine
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
DE69016956T2 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
HUP9802819A2 (hu) Hősokkfehérje-alapú oltóanyagok és immunterápiák
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
DE3888086T2 (de) Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
DE3853088T2 (de) Rekombinantes Avipoxvirus.
DE3850019T2 (de) Rekombinantes Avipoxvirus.
FR2620459B1 (fr) Virus recombinant de la vaccine
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
AU3426889A (en) Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
DE69818913D1 (de) Rekombinanter Birnavirusimpfstoff
ATE109158T1 (de) Rubella-e1 und c peptide.
ATE134878T1 (de) Impfstoffe gegen metazoen-parasiten
DE69428984D1 (de) Stimulierung der immunantwort durch virales protein
KR900700604A (ko) 오이 모자이크 바이러스 코트 단백질 유전자
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
NO942075L (no) Rekombinante virus omfattende kunstig proteolytisk spaltingssete